TY  - JOUR

T1  - Abstract S3-3: The UK TACT2 Trial: comparison of standard vs accelerated epirubicin in patients requiring chemotherapy for early breast cancer (EBC) (CRUK/05/019)

JO  - General Session Abstracts

PY  - 2012/12/15

AU  - Cameron D

AU  - Barrett-Lee P

AU  - Canney P

AU  - Banerji J

AU  - Bartlett J

AU  - Bloomfield D

AU  - Bowden S

AU  - Brunt M

AU  - Earl H

AU  - Ellis P

AU  - Fletcher M et al

ED  - 

DO  - DOI: 10.1158/0008-5472.sabcs12-s3-3

PB  - American Association for Cancer Research

Y2  - 2025/10/10

ER  -